Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency
Ying Li, Dandan Yang, Yian Wang, Zhan Li, Chunyan Zhu Drug Delivery Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, People’s Republic of China Background: To establish the combination of doxorub...
Enregistré dans:
Auteurs principaux: | Li Y, Yang D, Wang Y, Li Z, Zhu C |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ea48108eafa8459e8410c0fda7ab82fb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mechanism of hepatic targeting via oral administration of DSPE–PEG–cholic acid-modified nanoliposomes
par: Li Y, et autres
Publié: (2017) -
Octanoyl galactose ester-modified microemulsion system self-assembled by coix seed components to enhance tumor targeting and hepatoma therapy
par: Qu D, et autres
Publié: (2017) -
Intelligently responsive amphiphilic small molecule loaded with doxorubicin to form highly effective anti-hepatocarcinoma nanomicelles
par: Chunxiao Gao, et autres
Publié: (2021) -
Liver-Targeting and pH-Sensitive Sulfated Hyaluronic Acid Mixed Micelles for Hepatoma Therapy
par: Li Z, et autres
Publié: (2019) -
Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4
par: Lian B, et autres
Publié: (2021)